Recently about 200 community members attended a marijuana and vaping educational forum at the Compass Church in Naperville.
If you enjoyed this video, click the like button and subscribe to our YouTube Channel!
Naperville Community Television broadcasts on Channel 17 in Naperville, IL (Comcast & WOW!) and all our programming is available via simulcast and video on-demand at https://www.nctv17.com/
For daily local news sent to your inbox, subscribe to NCTV17 News Update: https://www.nctv17.com/subscribe/
Follow us on:
Tweets by NCTV17
Recently about 200 community members attended a marijuana and vaping educational forum at the Compass Church in Naperville.The educational event was hosted by KidsMatter, and focused on the risks associated with marijuana and vaping, particularly with teens and young adults.How Weed Can Affect The BrainSeveral panelists spoke during the event, including Aaron Weiner, the director of addiction services at Linden Oaks Behavioral Health. He said smoking marijuana before the age of 25 can affect the brain’s hippocampus, which is associated with learning and memory and the frontal cortex, which affects a person’s personality.“These are not things that grow back. This isn’t like you get a scab and it comes back,” said Weiner. “When you’re growing up your brain grows in some places and inaudible in others. And if you introduce a chemical that changes that brain development you don’t get to have that back.”Weiner also mentioned that marijuana’s potency, has gone up in the last 20 years with the increase in its THC content.Vaping EpidemicThe panelists also discussed vaping and reasons why it has become prevalent with youth. One is the name of vaping flavors like “Blueberry Cheesecake”, which is marketed toward young people.At the time of this story a total of 2,668 hospitalized e-cigarette, or vaping cases have been reported to the CDC, with ages ranging from as young as 15 to 75 years.The panelists said in order for the epidemic to slow down, teens and young adults will need to stop glorifying vaping on social media.KidsMatter’s next education series topic will be on stress and anxiety.
Speaking on the ‘Cannabis Education and Advocacy’ panel at the Central European Cannabis Forum in Warsaw, Poland on October 23rd, 2019:
Mike explains that the stalling of the health ministry to repeal cannabis prohibition is not unique or accidental. Rich oligarchs around the world are doing everything they can to keep patients from growing at home because they can not profit off home growers.
Follow Us On Facebook: www.Facebook.com/MikeWiseShowOfficial
And Instagram: @MikeWiseShow
If you would like to purchase high quality, Non-GMO seeds check out: www.OGLabsGenetics.com/seeds.html
An online survey circulated among physicians who treat Parkinson’s disease found that 80% of their patients had used cannabis to treat their symptoms. Furthermore, 95% of the neurologists polled said they’d been asked by their patients for a doctor’s recommendation to use medical marijuana.
Results of the survey, undertaken in partnership with the Parkinson’s Foundation and Northwestern University in Illinois, inspired a conference that was held in Denver on March 6 and 7, 2019. Some 45 experts from the United States, Canada, and Europe gathered to discuss the use and implications of medical marijuana for people with Parkinson’s disease.
Survey Says: Let’s Talk About Medical Cannabis
The meeting marked the first time in its 62-year history that the Parkinson’s Foundation publicly discussed medical marijuana as a treatment for Parkinson’s disease symptoms.
“The results of the survey were alarming,” said Dr. Beth Vernaleo, Senior Director of Research Programs at the Parkinson’s Foundation. “Not only are the majority of patients using medical cannabis, but few physicians have received the training necessary in order to help guide their patients in its use.”
The goals of the Colorado meeting, which was led by Dr. James Beck, chief scientific officer of the Parkinson’s Foundation, included discussions about evidence for the use of medical cannabis in treating Parkinson’s disease, developing guidance for patients and physicians, outlining an agenda for future research and addressing gaps in knowledge, many of which stem from legal and regulatory issues that continue to hamper medical cannabis research.
“While the [Parkinson’s] Foundation cannot recommend the use of medical cannabis for Parkinson’s at this time due to lack of conclusive evidence of efficacy, our hope is to educate the patient and medical communities so they can make informed decisions regarding its use,” Vernaleo said.
Parkinson’s disease is the 14th-leading cause of death in the United States, the second-most common neurodegenerative disease after Alzheimer’s disease. It affects nearly 1 million Americans and 10 million people worldwide.
Although treatments can help relieve some of the physical or mental symptoms associated with neurodegenerative diseases, there is currently no way to slow the progression of Parkinson’s disease and there are no known cures.
“It is clear that people with Parkinson’s and their families are intensely interested in the potential of marijuana and cannabinoids to help manage symptoms and other aspects of the disease,” Kluger said. “There is a critical need to analyze existing data on medical marijuana and to set priorities for future research.”
Kluger noted that there is ample anecdotal evidence suggesting that cannabis may help several of Parkinson’s disease’s most common symptoms including pain, sleep dysfunction, appetite and weight loss, nausea and anxiety.
Medical Cannabis Treatment for Parkinson’s Disease?
A chronic degenerative disease of the central nervous system, Parkinson’s disease mainly affects the areas of the brain that are responsible for controlling bodily movement.
Although few randomized double-blind clinical trials have been carried out involving the effect of cannabis on Parkinson’s disease sufferers, Moisés García Arencibia, Ph.D., professor of cell biology at the University of La Laguna (ULL) in Spain‘s Tenerife, the largest of the Canary Islands, has researched how cannabis can help improve motor and non-motor skills in Parkinson’s disease patients.
In a 2011 study co-authored by Garcia Arencibia, published in the British Journal of Pharmacology, the researchers posited that if cannabis can slow down some of the neuron damage in the brain, it could be a promising therapy for alleviating and reducing the progression of Parkinson’s disease.
Cannabis’s anti-inflammatory and antioxidant properties may help prevent neuron damage. This is particularly important for Parkinson’s disease because inflammation may be responsible for causing damage to neurons in the brain that produce dopamine, one of the neurotransmitters that help regulate movement, attention, learning, and emotional responses.
When the brain fails to produce enough dopamine, it can result in Parkinson’s disease.
Preclinical work, including several studies funded by Michael J. Fox Foundation for Parkinson’s Research (MJFF), concur that cannabinoids may protect brain cells through antioxidant and anti-inflammatory mechanisms. This prompted the MJFF to call for the reclassification of marijuana in July 2016.
A working group in the Parkinson’s Foundation intends to publish a white paper discussing the state of cannabis research regarding Parkinson’s disease and will make recommendations for future study. The foundation will also develop educational materials for patients and doctors and draw up a consensus statement on the use of medical cannabis for treating Parkinson’s disease.
“Lastly, the foundation plans to release a request for applications for research into the use of medical cannabis for Parkinson’s later this year,” said Vernaleo, the Parkinson’s Foundation director.
“Now that medical cannabis is legal in 33 states and the District of Columbia, it has become clear that this is a topic the Parkinson’s Foundation needs to address to help ensure the safety of the Parkinson’s community.”
Pa. state Rep. Ed Gainey hosts a cannabis education forum to gather feedback from constituents on legalizing and decriminalizing adult-use cannabis. More at http://www.pahouse.com
Pa. state Rep. Ed Gainey is hosting a Cannabis Education Forum on Saturday, January 26, 2019 from Noon – 4 p.m. at Homewood Brushton Carnegie Library, Auditorium, 7101 Hamilton Avenue
Pittsburgh, PA 15208. It will focus on having an open and honest conversation about the decriminalization/legalization of marijuana. More at http://www.pahouse.com/Gainey
Join us on Saturday, October 6, 2018 for “Problems with Marijuana: An ACO Sponsored Forum” at Rutgers University Conference Center in New Brunswick, NJ from 3:00PM to 6:00PM.
Doctors and other professionals working in the trenches with drug addiction will tackle the abundance of misinformation about marijuana and marijuana use by young adults. The forum will feature a variety of speakers from different walks of life who will offer their perspective on the subject.
The keynote speaker, Dr. Theodore Petti, is a nationally recognized expert with many years of research experience who has consulted with the New Jersey legislature on the subject. He is Professor of Psychiatry at Rutgers-Robert Wood Johnson Medical School and President of the American Society of Adolescent Psychiatry. Dr. Petti has spoken across the globe on issues related to cannabis in adolescents and emerging adults.
Representatives from two internationally renowned websites promoting marijuana education—Julie Schauer, founder of Parents Opposed to Pot, and Kimberly Hartke representing Moms Strong—will offer their views on marijuana use by young people.
ACO president Peter A. Crist, M.D. will introduce the program, and therapists Dee Apple, Ph.D., Edward Chastka, M.D. and Dale Rosin, D.O. will present cases involving individuals whose lives were disrupted by marijuana.
There will also be a rare opportunity to hear how one drug-free teenager manages a world where marijuana use by her peers in and outside of school is common; and from another young person willing to share details about her recovery from substance abuse. A question-and-answer section allowing the audience to interact with the presenters concludes the program.
Watch our video for insights about marijuana use and what will be happening at the forum from forum co-coordinators and presenters, Dr. Dee Apple and Dr. Edward Chastka.
To view the full forum schedule and presenter biographies, or to register in advance please visit our website at http://www.orgonomy.org.
Admission: $50; $15 for full-time students (under age 30 with valid student ID). Advance registration is highly recommended.
A longer, in-depth video is now available for viewing. https://youtu.be/10Bl_uxoaao
On Saturday, October 6, 2018 the ACO presented “Problems with Marijuana: An ACO Sponsored Forum” at Rutgers University Conference Center in New Brunswick, NJ.
Doctors and other professionals working in the trenches with drug addiction tackled the abundance of misinformation about marijuana and marijuana use by young adults. The forum featured a variety of speakers from different walks of life who offered their perspective on the subject.
Keynote speaker, Dr. Theodore Petti, is a nationally recognized expert with many years of research experience who has consulted with the New Jersey legislature on the subject. He is Professor of Psychiatry at Rutgers-Robert Wood Johnson Medical School and President of the American Society of Adolescent Psychiatry. Dr. Petti has spoken across the globe on issues related to cannabis in adolescents and emerging adults.
Representatives from two internationally renowned websites promoting marijuana education—Julie Schauer, founder of Parents Opposed to Pot, and Kimberly Hartke representing Moms Strong—offered their views on marijuana use by young people.
ACO president Peter A. Crist, M.D. introduced the program, and therapists Dee Apple, Ph.D., Edward Chastka, M.D. and Dale Rosin, D.O. presented cases involving individuals whose lives were disrupted by marijuana.
There was also a rare opportunity to hear how one drug-free teenager manages a world where marijuana use by her peers in and outside of school is common; and from another young person willing to share details about her recovery from substance abuse. A question-and-answer section allowing the audience to interact with the presenters concluded the program.
Find out more about the ACO at http://www.orgonomy.org
The 3rd Annual Cannabis Education Forum is a space where law makers, medical professionals, advocates, activists, lawyers, law enforcement, cannabis professionals and anyone who wants to learn and educate can have an open and on the record discussion about the current state of the cannabis industry with the public at large. The event seeks to empower members of the community to meet the many challenges and opportunities of the emerging marijuana market. Specifically, this year’s forum will feature speakers and panelists who will focus on the issues and opportunities facing the market in light of the upcoming legalization in 2018.